iiinova — where your digital self keeps evolving

KenOliveLab @kenolivelab.bsky.social · 24/06/2026

Today is Day 6, with lectures by John Preall (bioinformatics), Tony Hollingsworth (rapid autopsy programs and biobanking) in the morning. Then an afternoon of "RAS-opolooza" with Channing Der (RAS biology and history) and Mallika Singh (RAS inhibition).

KenOliveLab @kenolivelab.bsky.social · 24/06/2026

Day 5 included lectures by Katy Wellen (tumor metabolism and epigenetic regulation), @rushika-perera.bsky.social (cell biology), @teresazimmers.bsky.social (cachexia), and @benstanger01.bsky.social (metastasis).

KenOliveLab @kenolivelab.bsky.social · 24/06/2026

I fell behind on posting. Day 4 of #CSHLPDAC26 included lectures by Danni Engle (Model Systems), Laura Wood (early lesions), Bryson Katonah (epidemiology), and me (mouse models and translational research).

KenOliveLab @kenolivelab.bsky.social · 21/06/2026

Day 3 of #CSHLPDAC2026! Cancer immunology day, with a tag-team lineup from Stephanie Dougan and Kate Byrne.

020

KenOliveLab @kenolivelab.bsky.social · 20/06/2026

I just mis-clicked and hit Accept on a paper review that I meant to decline. 🤦‍♂️ Sigh.

KenOliveLab @kenolivelab.bsky.social · 20/06/2026

Day 2 of the CSHL PDAC. Marina Pasca di Magliano kicks off with an intro to the TME, Nina Steele discusses endothelial cells, @marasherman.bsky.social covers nerves, and @tme-caf-ecm.bsky.social explains the ECM. Capped off by tumor plasticity and subtypes by @hccvpdac.bsky.social.

KenOliveLab @kenolivelab.bsky.social · 19/06/2026

Really excited to welcome this year's class of students to the 2026 Cold Spring Harbor course on Pancreatic Cancer! Kicking off the course with a day of clinical education from @anirbanmaitra.bsky.social, @filbednar.bsky.social , Andy Aguirre, @manciaslab.bsky.social & @benstanger01.bsky.social.

050

KenOliveLab @kenolivelab.bsky.social · 31/05/2026

My lab had a watch party for Brian Wolpin's plenary lecture at ASCO reporting the results of the RASolute 302 Phase 3 trial of daraxonrasib in previously-treated metastatic PDAC. TWO standing ovations. So incredibly excited to see these results.

191

KenOliveLab @kenolivelab.bsky.social · 27/05/2026

I know, right? It's like asking my teenager how school went.

KenOliveLab @kenolivelab.bsky.social · 26/05/2026

Like, do you not realize that your experimental results are the high-point of my day???

KenOliveLab @kenolivelab.bsky.social · 26/05/2026

I swear some of my lab members like to torture me by holding off telling me about their results. When I was a student, I had NO CHILL - the second I had a result, I wanted to tell everyone about it. Now my students are like "oh, I'll tell you about that next week in lab meeting". WTF!?!?!

270

KenOliveLab @kenolivelab.bsky.social · 20/04/2026

Super proud of my postdoc, Alvaro Curiel-Garcia @alvarocuriel.bsky.social for his Rising Star lecture at #AACR26. Alvaro has a Nature Genetics cofirst author paper in press, and another 1st author manuscript that is in revision, also at Nature Genetics. He's on the job market folks!

KenOliveLab @kenolivelab.bsky.social · 13/04/2026

2L+ metatstatic pancreatic ductal adenocarcinoma

KenOliveLab @kenolivelab.bsky.social · 13/04/2026

Daraxonrasib median OS 13.2 months vs. 6.7 for chemotherapy. Phase 3 randomized controlled trial. I'm so happy. ir.revmed.com/news-release...

ir.revmed.com

1102

Reposted by KenOliveLab

AndreaVentura @andreaventura.bsky.social · 18/03/2026

We are seeking a highly motivated scientist with expertise in mouse embryo manipulation and the generation of genetically engineered mouse models. This is a permanent position with competitive compensation. Contact me via direct message if interested. Please share!

014

KenOliveLab @kenolivelab.bsky.social · 03/03/2026

Um, does this only work for highly enriched uranium? Asking for (all my) friends who live on a continent where uranium mining occurs...

100

KenOliveLab @kenolivelab.bsky.social · 05/02/2026

Same. Fortunately the NIH has indicated that they will be flexible for this deadline about NIH biosketch formats

020

KenOliveLab @kenolivelab.bsky.social · 03/02/2026

I'm sorry, I can't really celebrate this. Up to 40% MYF is devastating for funding rates. Many careers will be ended because this provision was left in. This was a failure.

Columbia Department of Medicine @cuimcmedicinedept.bsky.social · 30/01/2026

Reposted by KenOliveLab

Did you know pancreatic tumors plan their travels? Learn more about this fascinating new discovery: www.cancer.columbia.edu/news/pancrea...

041

Reposted by KenOliveLab

Jenna Norton @jenna-m-norton.bsky.social · 20/01/2026

The language on multiyear funding (MYF) is ineffective. Final bill anchors MYF to 2025 instead of 2024. This means MYF will likely continue at the same rate we saw last year, where NCI's payline from ~10% to 4%. This is incredibly harmful to the US research workforce - especially early career.

32929

Reposted by KenOliveLab

Princess Vimentin PhD | Cancer Biologist @princess-vimentin.bsky.social · 22/01/2026

🧪IMPORTANT! This graphic explains how science all over the US is funded. Congress approved a 2% increase in the #NIH budget for FY 26. Buried in the bill- Shift of ~40% of grants to MYF. This will still result in a 35% DECREASE in the NUMBER of grants funded per yr. Russel Vought is behind this.

Graphic helps visualize how MYF funds FEWER grants despite the increase in budget approval by Congress.

https://www.researchamerica.org/wp-content/uploads/2025/11/ACT-for-NIH-Multi-Year-Funding-One-Pager_October-2025.pdf

10211142

Reposted by KenOliveLab

Needhi Bhalla 💅🏽 @needhibhalla.bsky.social · 20/01/2026

The NIH's MYF policy in 2025 resulted in 4000 fewer grants and fellowships that touched every area of biology and medicine; continuing it in 2026 would be disastrous for science, technology and health in the United States 🧪 www.nytimes.com/interactive/...

nytimes.com

The U.S. Is Funding Fewer Grants in Every Area of Science and Medicine

A quiet policy change means the government is making fewer bets on long-term science.

28669

Reposted by KenOliveLab

David Ho @davidho.bsky.social · 20/01/2026

This is the most astonishing graph of what the Trump regime has done to US science. They have destroyed the federal science workforce across the board. The negative impacts on Americans will be felt for generations, and the US might never be the same again. www.nature.com/immersive/d4...

This line graph illustrates the percentage change in agency staff levels from the previous year for nine major U.S. federal scientific and health organizations between the fiscal years 2016 and 2025. The agencies tracked include the CDC, Department of Energy, EPA, FDA, NASA, NIH, NIST, NOAA, and NSF. For the majority of the timeline between 2016 and 2023, the agencies show relatively stable fluctuations, generally staying within a range of +5% to -5% change per year. However, there is a dramatic and uniform plummet starting in the 2024–25 period. Every agency depicted shows a sharp downward trajectory, with staffing losses ranging from approximately -15% to over -25%. The Environmental Protection Agency (EPA) shows the most significant decline, dropping to roughly -26%, while the National Institute of Standards and Technology (NIST) shows the least severe but still substantial drop at approximately -15%.

91147788500

KenOliveLab @kenolivelab.bsky.social · 19/01/2026

I understand that historically PubMed didn't populate coauthorships, but surely this can be fixed going forward. And I can't think of a better use-case for LLMs than to retroactively annotate every paper in PubMed with coauthorship data... we owe it to our trainees to fix this.

KenOliveLab @kenolivelab.bsky.social · 19/01/2026

By mandatory, I mean that all NIH grants starting this month must use ScienCV for generating biosketches. Since the system pulls from NCBI's MyBibliography (and by extension PubMed), co-authorships are not indicated.

100

KenOliveLab @kenolivelab.bsky.social · 19/01/2026

It is a PROBLEM that the new MANDATORY ScienCV platform does not (as far as I can tell) enable one to indicate co-first or co-senior authorship in your bibliography. This is a massive disincentive to collaborative science and it needs to be fixed.

1165

KenOliveLab @kenolivelab.bsky.social · 06/01/2026

NIH - you can ONLY use our proprietary system to generate your biosketch. Simply typing it up isn't allowed. Ready GO! Everyone has to start using it RIGHT NOW! Also NIH - what do you mean they ScienCV is barely functional and hangs every time you use it? no idea what your talking about...

030

KenOliveLab @kenolivelab.bsky.social · 13/10/2025

Dear journal editors, what do we think about including summary figures in a cover letter? I've never done this, but a co-author wants to include one for our latest manuscript. Helpful in illustrating the case? Weird and gauche? What say ye?

KenOliveLab @kenolivelab.bsky.social · 01/08/2025

The ghost of USAID enters and the room gets quiet...

2890

KenOliveLab @kenolivelab.bsky.social · 25/06/2025

Among the highest compliments that I've received have been the times colleagues mentioned that their lab reviewed one of my papers in their journal club.

Finally, a huge thanks to all of our incredible students at #CSHLPDAC25. This was a standout class who leaned into the science, the questions, and... UNO! Look forward to seeing you all at meetings for many years to come!

030

and Channing Der (RAS), Jen Jen Yeh (Tumor/Stroma subtyping). Also, a huge shoutout to my fellow course directors, Marina Pasca de Magliano, Ben Stanger @benstanger01.bsky.social, and Tony Hollingsworth.

Howard Crawford @hccvpdac.bsky.social (Tumor Bio I), Herve Tiriac @htiriac.bsky.social ‬ (Model Systems II), Teresa Zimmers @teresazimmers.bsky.social ‬ (Cachexia), Costas Lyssiotis @lyssiotislab.bsky.social, Rushika Perera @rushika-perera.bsky.social (Autophagy), Faiyaz Notta (Genetics/Genomics)..

So, I dropped the ball in my #CSHLPDAC25 posts. Huge shout out to all of the instructors I didn't get to highlight with photos, including: Ingunn Stromnes (Immunology I), David DeNardo (Immunology II), Bryson Katona (Epidemiology and Early Detection)...

KenOliveLab @kenolivelab.bsky.social · 12/06/2025

Every time a school implements this policy, behavior problems go down and learning metrics go up. If you need to talk to your kid, you call the main office, just like every prior generation did in the past.

KenOliveLab @kenolivelab.bsky.social · 12/06/2025

OMG I've never supported a measure more. As does every single teacher I've ever met. Both my kids schools ban phones and it changes every aspect of behavior for the kids. All for the better.